Market Tracker

02/24 5:16pm ET

AbbVie Inc (NYSE:ABBV)

62.09
Delayed Data
As of Feb 24
 +0.15 / +0.24%
Today’s Change
54.01
Today|||52-Week Range
68.12
-0.85%
Year-to-Date
3 Incredibly Cheap Biotech Stocks
Feb 24 / MotleyFool.com - Paid Partner Content
No Joke: Johnson & Johnson Could Grow Sales by 5% (or More) Annually Over the Next De...
Feb 15 / MotleyFool.com - Paid Partner Content
These 3 Dividend Stocks Are Ridiculously Cheap
Feb 23 / MotleyFool.com - Paid Partner Content
Gilead (GILD) Announces Data on Combination Therapy for HIV
Feb 14 / Zacks.com - Paid Partner Content
AbbVie Declares Quarterly Dividend
Feb 21 / GuruFocus News - Paid Partner Content
Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More
Feb 13 / Zacks.com - Paid Partner Content
Pfizer's Xeljanz Combo Comparable to AbbVie's Humira
Feb 17 / Zacks.com - Paid Partner Content
3 Top Biotech Stocks to Buy on Sale
Feb 13 / MotleyFool.com - Paid Partner Content
Why I Just Bought AbbVie Stock
Feb 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close61.94
Today’s open61.92
Day’s range61.49 - 62.23
Volume6,536,399
Average volume (3 months)7,796,470
Market cap$99.0B
Dividend yield4.12%
Data as of 4:02pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+14.00%
Earnings growth (next 5 years)+12.20%
Revenue growth (last year)+12.16%
P/E ratio17.1
Price/Sales3.98
Price/Book21.33

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.07+0.17%
BMYBristol-Myers Squibb+0.67+1.20%
AGNAllergan-1.66-0.67%
CELGCelgene-1.23-1.03%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateApril 28, 2017
EPS forecast (this quarter)$1.26
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts